Chemokine-receptor expression profiling in biological samples from human clinical trials
Ended Project Grant Awarded Last action
- Award ID
- R43NS108887
- Recipient
-
Plumeria Therapeutics Inc. UEI EMZ9GH4XKEJ4
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $280,001
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Place of performance
- Princeton Junction, West Windsor Township, NJ, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $55,000 | |
| Original award | $225,001 |
Quick answers
Who received award R43NS108887?
R43NS108887 was awarded to Plumeria Therapeutics Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 1, 2018.
How much is award R43NS108887 worth?
$280,001 has been obligated on R43NS108887.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award